Dr. Volker Viktor has a diverse range of work experience in the healthcare and pharmaceutical industries. Dr. Volker is currently serving as the Vice President and Global Head of Commercial Excellence & Strategy at Aenova Group. In this role, they lead teams focused on sales and marketing excellence, sales effectiveness, commercial operations, pricing, and market intelligence. Dr. Volker is also a member of the global leadership team at the company.
Prior to their current position, Dr. Viktor worked as a Guest Lecturer in Healthcare Management at the Karlsruher Institut für Technologie (KIT) starting in 2012. Dr. Volker also held the position of Senior Manager in Life Science & Pharma at Accenture Strategy from 2016 to 2020.
Before joining Accenture Strategy, Dr. Viktor worked at Consileon Business Consultancy in various roles including Practice Group Co-Lead, Project Manager, Senior Consultant, and Consultant. Dr. Volker was responsible for projects in the pharma and healthcare sectors during their time at Consileon, starting in 2010 and ending in 2016.
In addition, Dr. Viktor gained experience as a Consultant in Healthcare & Public Services at Kienbaum Management Consultants from 2009 to 2010. Dr. Volker also worked as a Research Assistant in Digital Health at Bosch Healthcare from 2008 to 2008.
Overall, Dr. Volker Viktor has a strong background in healthcare management, strategy, and consultancy, with a focus on the pharmaceutical industry.
Dr. Volker Viktor has a strong education background. Dr. Volker holds a Diplom degree in Health Economics from the University of Bayreuth, which they obtained from 2003 to 2009. Dr. Volker also pursued further education and completed a Dr. rer. pol. degree in Business Administration with a specialization in Health Economics from the University of Bayreuth between 2012 and 2015. Additionally, Dr. Viktor is currently pursuing Executive MBA degrees in General Management & Leadership from both Northwestern University - Kellogg School of Management and WHU – Otto Beisheim School of Management, with an expected completion date in 2024.
Sign up to view 5 direct reports
Get started